SYNTEX WILL RUN NAPROSYN CORRECTIVE ADS IN 18 MEDICAL JOURNALS AND ON "LIFETIME" TV IN COURT-FILED CONSENT DECREE TO HALT ARTHROPROTECTIVE CLAIMS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".